Cargando…

Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity

Hyperechogenicity of substantia nigra (SNh) is a frequent finding in amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD) and other movement disorders (MD) patients, but its meaning is unclear. To ascertain the contribution of different factors to SNh area, we measured it in 108 ALS, 102 PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez-Costa, Juan F., Tembl, José I., Fornés-Ferrer, Victoria, Cardona, Fernando, Morales-Caba, Lluis, Fortea, Gerardo, Pérez-Tur, Jordi, Sevilla, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541052/ https://www.ncbi.nlm.nih.gov/pubmed/28769074 http://dx.doi.org/10.1038/s41598-017-07835-z

Ejemplares similares

Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease
por: Yilmaz, Rezzak, et al.
Publicado: (2016)

Clinical Features in Parkinson’s Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study
por: Zhu, Sha, et al.
Publicado: (2022)

Hyperechogenicity of the Substantia Nigra in Parkinson's Disease: Insights from Two Brothers with Markedly Different Disease Durations
por: Hall, Julie M., et al.
Publicado: (2017)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Substantia nigra hyperechogenicity in Parkinson disease patients with leucine-rich repeat kinase 2 variants in the Chinese Han population
por: Li, Kai, et al.
Publicado: (2020)

Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson’s Disease and Atypical Parkinsonian Syndromes
por: Fujita, Hiroaki, et al.
Publicado: (2016)

Soemmerring and the Substantia Nigra
por: Faull, R. L. M, et al.
Publicado: (1968)

The substantia nigra is a major target for neurovirulent influenza A virus
Publicado: (1995)

The history of the research of iron in parkinsonian substantia nigra
por: Friedman, Andrzej, et al.
Publicado: (2012)

Isolated substantia nigra involvement in brainstem demyelination
por: Mahale, Rohan R., et al.
Publicado: (2015)

Nicotine impact on rat substantia nigra compacta
por: Elgayar, Sanaa A M, et al.
Publicado: (2021)

Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients
por: Fernández, Belén, et al.
Publicado: (2017)

Enhanced training protects memory against amnesia produced by concurrent inactivation of amygdala and striatum, amygdala and substantia nigra, or striatum and substantia nigra
por: Salado-Castillo, Rigoberto, et al.
Publicado: (2011)

Proteome analysis of human substantia nigra in Parkinson's disease
por: Werner, Cornelius J, et al.
Publicado: (2008)

Bidirectional Modulation of Substantia Nigra Activity by Motivational State
por: Rossi, Mark A., et al.
Publicado: (2013)

Operant Self-Stimulation of Dopamine Neurons in the Substantia Nigra
por: Rossi, Mark A., et al.
Publicado: (2013)

Epstein-Barr virus encephalitis with substantia nigra involvement
por: Çelik, Tamer, et al.
Publicado: (2015)

Mesencephalic origin of the rostral Substantia nigra pars reticulata
por: Madrigal, M. Pilar, et al.
Publicado: (2015)

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains
por: Gegg, Matthew E, et al.
Publicado: (2012)

Degeneration of the Substantia Nigra Following Ipsilateral Striatal Infarction
por: Ohtomo, Gaku, et al.
Publicado: (2017)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
por: Faynveitz, Anna, et al.
Publicado: (2019)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
por: Loeffler, David A, et al.
Publicado: (2006)

Parcellation of the human substantia nigra based on anatomical connectivity to the striatum()
por: Chowdhury, Rumana, et al.
Publicado: (2013)

Tollip, an early regulator of the acute inflammatory response in the substantia nigra
por: Humbert-Claude, Marie, et al.
Publicado: (2016)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
por: Dölle, Christian, et al.
Publicado: (2016)

Age-Mediated Transcriptomic Changes in Adult Mouse Substantia Nigra
por: Gao, Lin, et al.
Publicado: (2013)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
por: Seyfried, T. N., et al.
Publicado: (2018)

Anatomical and functional organization of the human substantia nigra and its connections
por: Zhang, Yu, et al.
Publicado: (2017)

Regional microglial activation in the substantia nigra is linked with fatigue in MS
por: Singhal, Tarun, et al.
Publicado: (2020)

The effect of titanium dioxide nanoparticles on mice midbrain substantia nigra
por: Heidari, Zahra, et al.
Publicado: (2019)

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
por: Trist, Benjamin G., et al.
Publicado: (2019)

Complementary Transcriptomic and Proteomic Analysis in the Substantia Nigra of Parkinson's Disease
por: Dong, Bao-hua, et al.
Publicado: (2021)

Angiotensin-II Modulates GABAergic Neurotransmission in the Mouse Substantia Nigra
por: Singh, Maibam R., et al.
Publicado: (2021)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
por: Feraco, Paola, et al.
Publicado: (2021)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
por: Liu, Lei, et al.
Publicado: (2023)

Activity of the Substantia Nigra Pars Reticulata during Saccade Adaptation
por: Kojima, Yoshiko, et al.
Publicado: (2023)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
por: Hussain, Sayyed Shahid, et al.
Publicado: (2023)

Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease
por: Farmer, Kyle, et al.
Publicado: (2015)

Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive “low footprint” genetic knockout of alpha-synuclein
por: Goloborshcheva, Valeria V., et al.
Publicado: (2020)

The Role of the Substantia Nigra Pars Compacta in Regulating Sleep Patterns in Rats
por: Lima, Marcelo M.S., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_jrs7jj5ouir2srdsuklme2gt19